Aquila Diagnostic Systems Inc. to Present at Venture Summit West
Aquila Diagnostics is pleased to announce that has it been selected to present at the third annual Venture Summit West in Mountain View California on February 28-March 1.
Aquila Diagnostic Systems Inc. Raises $1.75 Million Investment in Series A Financing
June 16, 2016 - Aquila Diagnostic Systems Inc., announces the closing of a $1.75 million Series A financing round with Benslie International Ltd.
Aquila Diagnostic Systems Inc. is a privately held Canadian company commercializing its innovative Accutas solution for a point-of-care molecular (DNA/RNA) diagnostic testing system. The patented Accutas solution provides low cost, laboratory quality diagnostics at the point-of-care, eliminating cost and inconvenience of waiting days or weeks for laboratory results to be returned and the subsequent follow-up visit or treatment. Aquila is preparing to enter large markets for the companion animal and food production sectors.
“Having something that can be out in the field, that can be affordable at a more local level and that doesn't need sophisticated laboratory technicians or laboratory equipment is going to be really invaluable.”
Dr. Maxine Whittaker, Co-Secretariat of the Asia Pacific Malaria Elimination Network (APMEN) and Professor of International and Tropical Health of the School of Public Health at the University of Queensland, Australia.